ANNOUNCEMENT

Save $300 on MedCity CONVERGE Healthcare Innovation Summit July 9-10 in Philadelphia. Earlybird rate ends May 20.

Topic: Azelon Pharmaceuticals

Nasal spray osteoporosis drug firm raising $2.4 million in new round

Nasal spray osteoporosis drug firm raising $2.4 million in new round

March 21, 2012 11:16 am by | 0 Comments

A company with a nasal spray formulation to treat osteoporosis is raising $2.4 million as it seeks to move its treatment through clinical trials, according to a Form D filing ... Read more
Azelon secures $4.5 million in Series A funding, restructures company

Azelon secures $4.5 million in Series A funding, restructures company

October 11, 2011 1:49 pm by | 0 Comments

Azelon Pharmaceuticals in West Conshohocken, Pennsylvania, has received $4.5 million in Series A financing from three venture capital firms to develop its nasal spray formulation of teriparatide for the treatment ... Read more